Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study.
2012 · PubMed · 3 citations
L
Li Wei Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
190
Citations
7
h-index
4
i10-index
Li Wei Wang is an academic researcher from Hebei University of Science and Technology. The author has contributed to research in topics: Advanced Sensor and Control Systems & Industrial Technology and Control Systems & Advanced Photocatalysis Techniques. The author has an h-index of 7, co-authored 33 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat